Metanomics Health Launches its Energy Metabolite Platform - a Unique Target Platform Based on Metabolite Profiling|
Friday, July 08, 2011
The targeted platform maps key metabolites affecting the energy status of a biological system.
Metabolons Vitamin D Deficiency Test Now Available for Patient Analysis
Thursday, July 07, 2011
Tandem mass spectrometry test run in Company’s CLIA registered laboratory.
Thermo Fisher Scientific Announces Breakthrough Workflow for Metabolomics Research
Tuesday, June 28, 2011
A new generation of application software with cutting-edge Orbitrap LC-MS technology advances metabolomics research.
New Q-TOF LC/MS Offers 10 Times More Sensitivity
Wednesday, June 15, 2011
Agilent Technologies, Inc. introduces the 6550 iFunnel quadrupole time-of-flight liquid chromatography mass spectrometry (Q-TOF LC/MS) system. It increases TOF sensitivity to low femtogram levels while delivering fast acquisition to 50 spectra/sec, up to five orders of intra-scan dynamic range, and robust performance and operation.
Thermo Scientific Launches New GC-MS/MS Instrument for Superior Selectivity and Sensitivity at ASMS 2011
Wednesday, June 08, 2011
New triple quadrupole gas chromatography-mass spectrometry system designed to offer best-in-class selectivity, analytical performance and productivity.
Thermo Fisher Scientific Introduces New High-Field Orbitrap Mass Spectrometer at ASMS 2011
Sunday, June 05, 2011
Novel high-field Orbitrap technology provides exceptional resolving power of >240,000 creating new possibilities in research and discovery.
Waters Introduces Highest Performing UPLC Ever Engineered – the new ACQUITY UPLC I-Class
Wednesday, June 01, 2011
The New ACQUITY UPLC I-Class System Takes Separations Technology to the Next Level by Maximizing Peak Capacity and Extending the Performance of any MS Detector.
PharmaGap Reports Significant Progress in Development of Liposomal Formulations of Cancer Drug GAP-107B8
Thursday, May 05, 2011
Initial testing of a liposomal delivery formulation for PharmaGap's lead cancer drug GAP-107B8 for therapeutic use in humans.
Olink Bioscience Introduces its New Plasma Biomarker Discovery Service
Monday, April 25, 2011
Using PLA® immunoassay platform, up to 74 potential cancer biomarkers are analyzed with high sensitivity in precious biobanked plasma samples, in no more than 2 µl of sample.